Skip to main content
. Author manuscript; available in PMC: 2014 Jul 1.
Published in final edited form as: Psychopharmacology (Berl). 2013 Feb 17;228(1):43–51. doi: 10.1007/s00213-013-3012-1

Figure 3.

Figure 3

[11C]-raclopride binding potential non-displaceable maps. Images correspond to averaged [11C]-raclopride binding potential maps of healthy controls (n=44) and patients with schizophrenia after 5-hour (n=11), 13-hour (n=11) and 23-hour (n=11) of the last dose of ziprasidone (60 mg). The binding potential maps are presented with an absolute threshold between 0 and 7 and in axial projection illustrating the dorsal striatum regions.